Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.67 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.67 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.67 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.67 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.67 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.67 |
| ▸ | DRD2 | P14416 | 2/20 | 0.65 |
| ▸ | DRD1 | P21728 | 2/20 | 0.65 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.65 |
| ▸ | LTA4H | P09960 | 1/20 | 0.60 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.59 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.59 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.59 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | CA12 | O43570 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | CA5A | P35218 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23754287 | 1.00 | GABRA1 (0.67) | GABRA1GABRG2GABRB3GABRA3GABRA2 | |
| SCHEMBL29449650 | 1.00 | GABRA1 (0.67) | GABRA1GABRG2GABRB3GABRA3GABRA2 | |
| SCHEMBL723832 | 0.93 | DRD2 (0.74) | GABRA1GABRG2GABRB3GABRA3GABRA2 | |
| 3-Phenethylphenol SCHEMBL717571 | 0.86 | OPRK1 (0.74) | GABRA1GABRG2GABRB3GABRA3GABRA2 | |
| Lunularin SCHEMBL717118 | 0.84 | LTA4H (0.64) | DRD2DRD1TAAR1LTA4HCHRM2 | |
| SCHEMBL4949943 | 0.84 | DRD2 (0.63) | GABRA1GABRG2GABRB3GABRA3GABRA2 | |
| Resorcinol SCHEMBL4639098 | 0.83 | OPRK1 (0.64) | DRD2DRD1TAAR1CHRM2CHRM1 | |
| SCHEMBL31674607 | 0.83 | DRD2 (0.68) | GABRA1GABRG2GABRB3GABRA3GABRA2 | |
| Dihydropinosylvin SCHEMBL501070 | 0.83 | LTA4H (0.70) | GABRA1GABRG2GABRB3GABRA3GABRA2 | |
| SCHEMBL11232474 | 0.83 | DRD2 (0.68) | DRD2DRD1TAAR1CHRM2CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114651723-B | Culture medium and method for inducing one-step seedling formation of rhododendron pseudobulb plant | 西南林业大学 | 2023-03-17 | — | — | CN | disclosed |
| CN-114651723-A | Culture medium and method for inducing one-step seedling formation of rhododendron pseudobulb plant | 西南林业大学 | 2022-06-24 | — | — | CN | disclosed |
| CN-109952286-B | Skin protection composition based on dendrobe components | 香港浸会大学 | 2022-03-22 | — | — | CN | disclosed |
| WO-2021160139-A1 | 9,10-DIHYDROPHENANTHRENE COMPOUNDS AND USE THEREOF IN TREATMENT OF LIVER INJURY | 中国科学院上海药物研究所 | 2021-08-19 | — | — | WO | disclosed |
| CN-110698328-A | Method for using dihydroresveratrol or stilbene derivatives and/or chemical variants thereof as antimicrobial agents | 香港浸会大学 | 2020-01-17 | — | — | CN | disclosed |
| CN-109952286-A | Skin protection composition based on Dendrobium ingredient | 香港浸会大学 | 2019-06-28 | — | — | CN | disclosed |
| US-10188590-B2 | Skin-protection composition containing Dendrobium-based ingredients | HONG KONG BAPTIST UNIVERSITY (HK) | 2019-01-29 | — | — | US | disclosed |
| US-10017442-B2 | Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatment of tumorous pathologies | HONG KONG BAPTIST UNIVERSITY (HK) | 2018-07-10 | — | — | US | disclosed |
| US-10017442-B2 | Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatment of tumorous pathologies | HONG KONG BAPTIST UNIVERSITY (HK) | 2018-07-10 | — | — | US | disclosed |
| US-10017442-B2 | Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatment of tumorous pathologies | HONG KONG BAPTIST UNIVERSITY (HK) | 2018-07-10 | — | — | US | disclosed |
| US-20170057906-A1 | SKIN-PROTECTION COMPOSITION CONTAINING DENDROBIUM-BASED INGREDIENTS | HONG KONG BAPTIST UNIVERSITY | 2017-03-02 | — | — | US | disclosed |
| US-20170057906-A1 | SKIN-PROTECTION COMPOSITION CONTAINING DENDROBIUM-BASED INGREDIENTS | HONG KONG BAPTIST UNIVERSITY | 2017-03-02 | — | — | US | disclosed |
| US-20170057906-A1 | SKIN-PROTECTION COMPOSITION CONTAINING DENDROBIUM-BASED INGREDIENTS | HONG KONG BAPTIST UNIVERSITY | 2017-03-02 | — | — | US | disclosed |
| US-20170057896-A1 | Method of Using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions | HONG KONG BAPTIST UNIVERSITY | 2017-03-02 | — | — | US | disclosed |
| US-20170057896-A1 | Method of Using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions | HONG KONG BAPTIST UNIVERSITY | 2017-03-02 | — | — | US | disclosed |
| US-9494864-B2 | Resist overlayer film forming composition for lithography and method for manufacturing semiconductor device using the same | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-11-15 | — | — | US | disclosed |
| CN-104996421-A | Application of diphenylethane compounds in dendrobium extract in plant pathogenic fungus prevention | UNIV HAINAN NORMAL | 2015-10-28 | — | — | CN | disclosed |
| US-20150248057-A1 | RESIST OVERLAYER FILM FORMING COMPOSITION FOR LITHOGRAPHY AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE USING THE SAME | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-09-03 | — | — | US | disclosed |
| US-5589620-A | ISOLATED FROM PLANTS; USEFUL IN TRANSFORMING VECTORS, HOST ORGANISMS AND PLANTS; PRODUCE PLANTS WHICH EXHIBIT AN INCREASED RESISTANCE TOWARDS PESTS | BAYER AKTIENGESELLSCHAFT (DE) | 1996-12-31 | — | — | US | disclosed |
| EP-0648839-A1 | Bibenzylsynthase gene | BAYER AG (DE) | 1995-04-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170057906-A1 | SKIN-PROTECTION COMPOSITION CONTAINING DENDROBIUM-BASED INGREDIENTS | TYR, MC1R, SYMPK | GABRA1 4423/4885GABRG2 4167/4885GABRB3 3190/4885 |
| US-10017442-B2 | Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatment of tumorous pathologies | VHL, ETV1, DHODH | GABRA1 4514/4885GABRG2 4707/4885GABRB3 3692/4885 |
| US-10188590-B2 | Skin-protection composition containing Dendrobium-based ingredients | TYR, MC1R, SYMPK | GABRA1 4489/4885GABRG2 4381/4885GABRB3 3475/4885 |
| US-20170057896-A1 | Method of Using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions | RNASE1, KRAS, DPP3 | GABRA1 4807/4885GABRG2 4811/4885GABRB3 4268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.